Seres Therapeutics, Inc. (MCRB) vs InspireMD, Inc. (NSPR)
A side-by-side comparison of Seres Therapeutics, Inc. and InspireMD, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MCRB
Seres Therapeutics, Inc.
$2.85HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
NSPR
InspireMD, Inc.
$0.56HealthcareDelayed quote: Oct 6, 2026, 12:19 PM EDT
Total return — MCRB vs NSPR
growth of $100 · dividends reinvested · last 10yMCRB -98.8% (-35.7%/yr)NSPR -100.0% (-68.2%/yr)MCRB compounded faster over this window
Log scale — wide-divergence pair
MCRB NSPR
MCRB vs NSPR: by the numbers
- •MCRB is the larger company ($28M vs $26M market cap).
- •Both run net losses; NSPR's is the smaller (-355.17% vs -1192.94% net margin).
- •NSPR grew revenue faster over the past five years (27.79% vs -42.51% CAGR).
Metrics side by side
Valuation
| Metric | MCRB | NSPR |
|---|---|---|
| P/S ratio | 14.66 | 2.42 |
| P/B ratio | 0.80 | 0.83 |
Profitability
| Metric | MCRB | NSPR |
|---|---|---|
| Gross margin | -423.83% | 29.50% |
| Operating margin | -11910.14% | -546.97% |
| Net margin | -1192.94% | -355.17% |
| ROE | -65.05% | -122.19% |
| ROIC | -103.04% | -153.04% |
Growth (annualized)
| Metric | MCRB | NSPR |
|---|---|---|
| Revenue CAGR (5Y) | -42.51% | 27.79% |
| Total return CAGR (5Y) | -53.37% | -36.91% |
Frequently asked
- Which has grown faster, MCRB or NSPR?
- Over the past five years, NSPR grew revenue faster — MCRB at a -42.51% CAGR versus NSPR at 27.79%.
- How have MCRB and NSPR total returns compared?
- Over the past 10 years, MCRB delivered -35.85% and NSPR delivered -68.24% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Seres Therapeutics ROEInspireMD ROESeres Therapeutics operating marginInspireMD operating marginSeres Therapeutics revenue growthInspireMD revenue growthSeres Therapeutics free cash flowInspireMD free cash flow
Seres Therapeutics & InspireMD appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.